Wang J - Search Results

1

Development of graded prognostic assessment for breast Cancer brain metastasis incorporating extracranial metastatic features: a retrospective analysis of 284 patients.

Wang Y, Xu H, Sa Q, Li L, Han Y, Wu Y, Zhou Y, Xu B, Wang J. Wang Y, et al. Among authors: wang j. BMC Cancer. 2024 Oct 10;24(1):1262. doi: 10.1186/s12885-024-12983-3. BMC Cancer. 2024. PMID: 39390441 Free PMC article.

2

[Docetaxel combined with cisplatin in the treatment of anthracycline-resistant advanced breast cancer].

Xu BH, Zhao LM, Wang JY, Yuan P. Xu BH, et al. Zhonghua Zhong Liu Za Zhi. 2006 Jun;28(6):471-3. Zhonghua Zhong Liu Za Zhi. 2006. PMID: 17152499 Chinese.

3

[Clinical characteristics and potential prognostic factors of breast cancer patients with liver metastases].

Wang JY, Xu BH, Tian LJ, Wang Y. Wang JY, et al. Zhonghua Zhong Liu Za Zhi. 2006 Aug;28(8):612-6. Zhonghua Zhong Liu Za Zhi. 2006. PMID: 17236558 Chinese.

4

Paclitaxel plus carboplatin for women with advanced breast cancer.

Liu J, Li Q, Zhang P, Wang JY, Zhao LM, Xu BH. Liu J, et al. Among authors: wang jy. Chin Med Sci J. 2007 Jun;22(2):93-7. Chin Med Sci J. 2007. PMID: 17763580

5

[Clinical characteristics and prognostic factors of female breast cancer patients with 10 or more positive lymph nodes: a report of 128 patients].

Guan Y, Xu BH, Li Q, Zhang P, Zhao LM, Yuan P, Wang JY. Guan Y, et al. Zhonghua Yi Xue Za Zhi. 2008 Jan 8;88(2):77-81. Zhonghua Yi Xue Za Zhi. 2008. PMID: 18353207 Chinese.

6

[Safety of adjuvant dose-dense chemotherapy with paclitaxel and epirubicin for high-risk breast cancer].

Wu WH, Li Q, Xu BH, Zhang P, Zhao LM, Yuan P, Wang JY, Cai RG, Zhou AP. Wu WH, et al. Zhonghua Zhong Liu Za Zhi. 2008 Jul;30(7):548-51. Zhonghua Zhong Liu Za Zhi. 2008. PMID: 19062727 Clinical Trial. Chinese.

7

[Goserelin plus anastrozole in the treatment of premenopausal patients with metastatic breast cancer].

Yao SY, Xu BH, Li Q, Zhang P, Wang JY, Yuan P, Ma F, Cai RG. Yao SY, et al. Zhonghua Yi Xue Za Zhi. 2010 Mar 2;90(8):526-8. Zhonghua Yi Xue Za Zhi. 2010. PMID: 20367963 Chinese.

8

Ixabepilone plus capecitabine for Chinese patients with metastatic breast cancer progressing after anthracycline and taxane treatment.

Wang J, Fan Y, Xu B. Wang J, et al. Cancer Chemother Pharmacol. 2010 Aug;66(3):597-603. doi: 10.1007/s00280-010-1362-5. Epub 2010 May 21. Cancer Chemother Pharmacol. 2010. PMID: 20490795 Clinical Trial.

9

Prospective study of vinorelbine and capecitabine combination therapy in Chinese patients with metastatic breast cancer pretreated with anthracyclines and taxanes.

Fan Y, Xu B, Yuan P, Wang J, Ma F, Li Q, Zhang P, Li Q, Cai R. Fan Y, et al. Among authors: wang j. Chemotherapy. 2010;56(4):340-7. doi: 10.1159/000320186. Epub 2010 Aug 18. Chemotherapy. 2010. PMID: 20720418 Clinical Trial.

10

Fulvestrant 250 mg versus anastrozole for Chinese patients with advanced breast cancer: results of a multicentre, double-blind, randomised phase III trial.

Xu B, Jiang Z, Shao Z, Wang J, Feng J, Song S, Chen Z, Gu K, Yu S, Zhang Y, Wang C, Zhang F, Yang J. Xu B, et al. Among authors: wang j, wang c. Cancer Chemother Pharmacol. 2011 Jan;67(1):223-30. doi: 10.1007/s00280-010-1483-x. Epub 2010 Oct 12. Cancer Chemother Pharmacol. 2011. PMID: 20938664 Clinical Trial.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

219,732 results

Search Page

Filters